Stock Rich List
#13438 on the rich list of 14,644 insiders

Robert Nelsen

Director at City Therapeutics; Director at Vir Biotechnology; Director at Prime Medicine. Based in Cambridge, Massachusetts.

$5.6M
in disclosed stock, −$174K (−3.03%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
13438th of 14,644
Companies held
3
Largest holding
VIR, 98.5% of total
Latest SEC filing
Oct 19, 2026
Listed but not counted
$466M

What the $5.6M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Vir Biotechnology VIR
Common Stock
Directly584,148$8.87$5.2M93.1%Form 4, May 30, 2024
Vir Biotechnology VIR
Common Stock
Indirectly (see filing footnote)33,893$8.87$301K5.4%Form 4, May 30, 2024
Prime Medicine PRME
Common Stock
Indirectly (see filing footnote)16,080$3.84$62K1.1%Form 4, Aug 1, 2025
Sana Biotechnology SANA
Common Stock
Indirectly (see filing footnote)12,500$1.74$22K0.4%Form 4, Feb 8, 2024
Sana Biotechnology SANA
Common Stock
Directly1,353$1.74$2K0.0%Form 4, Feb 8, 2024

Share counts are the amounts Robert Nelsen reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Robert Nelsen's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
City Therapeutics CTY
Common Stock
Through ARCH Venture Fund XII, L.P.
Held by a company or fund the insider manages
13,692,507$18.35$251M—Form 4, Oct 19, 2026
Vir Biotechnology VIR
Common Stock
Through ARCH Venture Fund IX Overage, L.P.
Held by a company or fund the insider manages
7,290,655$8.87$64.7M—Form 4, May 30, 2024
Vir Biotechnology VIR
Common Stock
Through ARCH Venture Fund IX, L.P.
Held by a company or fund the insider manages
5,626,008$8.87$49.9M—Form 4, May 30, 2024
Prime Medicine PRME
Common Stock
Through ARCH Venture Fund XII, L.P.
Held by a company or fund the insider manages
6,230,300$3.84$23.9M—Form 4, Aug 1, 2025
Prime Medicine PRME
Common Stock
Through ARCH Venture Fund X Overage, L.P.
Held by a company or fund the insider manages
6,128,297$3.84$23.5M—Form 4, Aug 1, 2025
Sana Biotechnology SANA
Common Stock
Through ARCH Venture Fund X, L.P.
Held by a company or fund the insider manages
12,446,022$1.74$21.7M—Form 4, Feb 8, 2024
Sana Biotechnology SANA
Common Stock
Through AVP IX LP
Held by a company or fund the insider manages
10,667,387$1.74$18.6M—Form 4, Feb 8, 2024
Lyell Immunopharma LYEL
Common Stock
ARCH Venture Fund IX Overage, L.P.
Held by a company or fund the insider manages
910,318
split-adjusted
$13.58$12.4M—Form 4, Jun 14, 2024

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 19, 2026BoughtCTY170,000$18.00$3.1MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
13435Dinkar S. Bhatia
See Remarks, X-Energy. Rockville, MD
$5.6M−$224K (−3.87%)
13436Richard F. Zannino
Director, People. New York, NY
$5.6M−$124K (−2.17%)
13437Mark A. Petrarca
Senior Vice Pres. - H.R. & P.A, A. O. Smith. Milwaukee, WI
$5.6M−$73K (−1.30%)
13438Robert Nelsen
Director, City Therapeutics. Cambridge, MA
$5.6M−$174K (−3.03%)
13439Michael Carlet
Chief Financial Officer, Resideo Technologies. Melville, NY
$5.6M−$214K (−3.70%)
13440Vincent Campagnoli
EVP, Technology & Operations, Raymond James Financial. St. Petersburg, FL
$5.6M−$119K (−2.10%)
13441Susan E. Arnold
Director, The Walt Disney. Burbank, CA
$5.6M−$98K (−1.72%)

Other City Therapeutics insiders

All CTY insiders

Questions

How much stock does Robert Nelsen own?

Robert Nelsen holds $5,567,875 in listed stock based on SEC filings and current prices, mostly Vir Biotechnology (VIR). That ranks 13438th on the Stock Rich List.

Is this Robert Nelsen's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Robert Nelsen last buy or sell stock?

The most recent open-market trade on file is a purchase of 170,000 CTY shares on Oct 19, 2026 at $18.00.